Summit Tx Capital, L.P. Viatris Inc Transaction History
Summit Tx Capital, L.P.
- $2.32 Trillion
- Q2 2025
A detailed history of Summit Tx Capital, L.P. transactions in Viatris Inc stock. As of the latest transaction made, Summit Tx Capital, L.P. holds 33,118 shares of VTRS stock, worth $337,472. This represents 0.01% of its overall portfolio holdings.
Number of Shares
33,118
Previous 11,013
200.72%
Holding current value
$337,472
Previous $95.9 Million
208.31%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding VTRS
# of Institutions
1,128Shares Held
986MCall Options Held
7.62MPut Options Held
2.97M-
Vanguard Group Inc Valley Forge, PA145MShares$1.48 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$944 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD78.8MShares$803 Million0.08% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az66.4MShares$676 Million3.26% of portfolio
-
State Street Corp Boston, MA55.3MShares$563 Million0.02% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $12.4B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...